FDA Inspection
MP Biomedicals Asia Pacific Pte LtdMP Biomedicals Asia Pacific Pte Ltd – FDA Inspection, Nov 7, 2016
Record Details
This FDA Inspection record concerns MP Biomedicals Asia Pacific Pte Ltd, with an inspection on November 7, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Person
- Omotunde O. Osunsanmi (Issuing Officer)
View Company Profile
ID · ef8f77ac-cf01-4e60-9907-350dbaec8508
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1002457
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of MP Biomedicals Asia Pacific Pte Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2025 | VAI | Office of Inspections and Investigations | Blood and Blood Products |
| December 14, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 13, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for MP Biomedicals Asia Pacific Pte Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.